TARGETSCAPE

Serial Number 79271806
Registration 6010552
700

Registration Progress

Application Filed
Aug 14, 2019
Under Examination
Approved for Publication
Dec 11, 2019
Published for Opposition
Dec 31, 2019
Registered
Mar 17, 2020

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200317)
Due: Mar 17, 2026 54 days

Trademark Image

TARGETSCAPE

Basic Information

Serial Number
79271806
Registration Number
6010552
Filing Date
August 14, 2019
Registration Date
March 17, 2020
Published for Opposition
December 31, 2019
Drawing Code
5000

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 17, 2020
Registration
Registered
Classes
001 042

Rights Holder

IMMUNOSCAPE PTE. LTD.

99
Address
1 Scotts Road,
#24-10 Shaw Centre Singapore 228208
SG

Ownership History

IMMUNOSCAPE PTE. LTD.

Original Applicant
99
SG

IMMUNOSCAPE PTE. LTD.

Owner at Publication
99
SG

IMMUNOSCAPE PTE. LTD.

Original Registrant
99
SG

USPTO Deadlines

Next Deadline
54 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200317)
Due Date
March 17, 2026
Grace Period Ends
September 17, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description Documents
May 15, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Apr 28, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 28, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Apr 16, 2020 GPAR P GRANT OF PROTECTION CREATED, TO BE SENT TO IB Loading...
Mar 17, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 4, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Dec 31, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 18, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 18, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Dec 11, 2019 NPUB O NOTICE OF PUBLICATION Loading...
Nov 25, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 22, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 18, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 18, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 14, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Laboratory reagents for scientific use; laboratory reagents for scientific use; reagents for laboratory purposes, other than for medical or veterinary purposes; reagents and reagents in kit form for scientific research use; diagnostic biochemical, chemical and biological reagents for laboratory or scientific purposes, other than for medical or veterinary use; reagents for use in biological analysis; reagents and reagents in kit form for immune profiling
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Laboratory research services in the field of biotechnology; laboratory research services in the field of immune profiling; laboratory research services in the field of vaccines; laboratory research services in the field of immunotherapy; laboratory research services in the field of immunotherapy products; laboratory research services relating to vaccines for use in the field of immunotherapy; laboratory research services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; laboratory research services, namely, probing for multiple t cell specificities for identification of tumor antigen-specific T cells for the treatment of cancer; laboratory research services, namely, probing for multiple T cell specificities for identification of viral antigen-specific T cells in the field of infectious diseases; laboratory research services, namely, phenotypic and functional t cell and/or other immune cells profiling for use in the field of immunotherapy; laboratory research services, namely, analysis by time-of-flight mass cytometry; laboratory research services, namely, analysis by flow cytometry; laboratory research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; laboratory research services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
TARGET SCAPE

Classification

International Classes
001 042